文献速递妇科生殖医学

多囊卵巢综合征自然史研究进展:纵向队列研究的系统综述

Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies.
PubMed 文献 · Hum Reprod · 2022-01-01

本系统综述纳入21项纵向队列研究共62123名15–49岁女性,随访4周至32年,发现多囊卵巢综合征(PCOS)女性的总睾酮和硫酸脱氢表雄酮(DHEAS)下降幅度大于无PCOS女性,且妊娠期糖尿病风险更高;其余结局证据不足或矛盾。

要点

  • PCOS女性总睾酮和DHEAS水平下降幅度大于无PCOS女性。
  • PCOS孕妇妊娠期糖尿病风险高于无PCOS孕妇。
  • 多数其他生殖、心理及肿瘤结局的纵向证据不明确。

核心结论

  • 现有关于PCOS生殖、心理和肿瘤特征变化的纵向数据不充分且存在矛盾。
  • 有限证据提示PCOS女性总睾酮和DHEAS水平下降幅度大于无PCOS女性。
  • 有限证据提示PCOS孕妇妊娠期糖尿病风险高于无PCOS孕妇。

研究设计与样本

  • 系统综述,纳入纵向队列研究,采用叙述性方式呈现结果。
  • 检索MEDLINE、EMBASE、Ovid PsycInfo、CINAHL PLUS和EBM reviews,检索时间2020年1月15日至2021年2月11日,无语言限制,仅纳入1990年至2021年2月发表的研究。
  • 纳入标准为女性PCOS患者,诊断依据2003年鹿特丹或1990年美国国立卫生研究院(NIH)共识标准。
  • 共纳入21项纵向研究,涵盖四大洲62123名参与者,基线年龄15至49岁,随访期4周至32年。

主要发现

  • 基于有限研究的 consistent 证据提示,PCOS女性总睾酮和DHEAS水平下降程度大于无PCOS女性。
  • PCOS孕妇妊娠期糖尿病风险高于无PCOS孕妇。
  • 由于信息矛盾或不足,其余大多数结局随时间变化的证据不明确。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究间在研究设置、人群特征、随访期、效应量测量和实验室检测方法方面存在极端异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the natural history of reproductive, psychological and oncological features in women with polycystic ovary syndrome (PCOS) in comparison to those without PCOS across the life course? SUMMARY ANSWER: Existing longitudinal data on changes in reproductive, psychological and oncological features in PCOS are inadequate and conflicting, but the limited evidence suggests that total testosterone (T) and dehydroepiandrosterone sulphate (DHEAS) levels decline more significantly in women with PCOS than in those without PCOS, and the risk of gestational diabetes is higher in pregnant women with PCOS compared to their counterparts without PCOS. WHAT IS KNOWN ALREADY: The progression of reproductive, psychological and oncological features in PCOS remains unclear, which limits prevention and early diagnosis strategies across the lifespan. Understanding the natural history of PCOS is one of the overarching priorities in PCOS research. STUDY DESIGN, SIZE, DURATION: This is a systematic review of longitudinal cohort studies with a narrative presentation of findings. Databases MEDLINE, EMBASE, Ovid PsycInfo, CINAHL PLUS and EBM reviews were searched between 15 January 2020 and 11 February 2021 with no language restrictions. Only studies published from the year 1990 to February 2021 were included. PARTICIPANTS/MATERIALS, SETTING, METHODS: In line with current guidelines for the assessment and management of PCOS, we included studies where participants were females with PCOS diagnosed according to the 2003 Rotterdam or the 1990 National Institutes of Health (NIH) consensus criteria. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 21 longitudinal studies including 62 123 participants over four continents reported reproductive, psychological and/or oncological outcomes. Participants were females aged between 15 and 49 years at baseline, with follow-up periods ranging from 4 weeks to 32 years. Consistent evidence based on limited studies suggests that total T and DHEAS levels decline to a greater degree in women with PCOS compared to those without PCOS, and the risk gestational diabetes is higher in women with PCOS than in those without PCOS. Evidence reporting changes over time in the majority of the remaining outcomes was unclear due to conflicting and/or insufficient information. LIMITATIONS, REASONS FOR CAUTION: There was extreme heterogeneity between studies in terms of study setting, population characteristics, follow-up period, effect measures used and laboratory testing approaches. WIDER IMPLICATIONS OF THE FINDINGS: Understanding the natural history of PCOS and changes in diagnostic, reproductive, psychological and oncological features of PCOS across the lifespan is still a challenge and the existing literature is both limited and conflicting. It is important that future long-term prospective longitudinal studies are conducted in unselected and well-characterized populations. STUDY FUNDING/COMPETING INTEREST(S): This specific study was not funded. S.K. is supported by scholarships from the Research Training Program of the Commonwealth of Australia and Monash University; H.J.T. is supported by an Australian National Health and Medical Research Council fellowship; and A.E.J. is supported by the Australian National Health and Medical Research Council's Centre for Research Excellence in Women's Health in Reproductive Life. R.A. was employed by the American Society for Reproductive Medicine and is a consultant to Spruce Biosciences and Fortress Biotech. The other authors have no conflicts of interest to declare. REGISTRATION NUMBER: Prospero registration number: CRD42020165546.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kiconco S, Tay CT, Rassie KL, et al. Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies. Hum Reprod. 2022. PMID: 35535684. doi:10.1093/humrep/deac077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。